BioWorld MedTech

Nov. 19, 2013

Deals roundup: CareFusion to acquire Vital Signs from GE for $500 million

CareFusion (San Diego) reported the signing of a definitive agreement to acquire the Vital Signs (Totowa, New Jersey) division of GE Healthcare (Chalfont, UK) for $500 million. Read More

Indian government seeking reforms: India looks to better regulate devices for the third time

Financings roundup: Solta secures $40 million for working capital and growth

Washington roundup: Device-intensive procedures named in report on outlier pay

American Academy of Ophthalmology meeting: IRIS Registry makes debut, pinpoints EHR opportunities

Agreements/contracts: Qiagen in diagnostics accord with Eli Lilly

HIT roundup: AliveCor launches its mobile heart health service

Grants roundup: NYU gets $10M from NIH for ISCHEMIA-CKD study

People in the News

Product Briefs

MDD's Cardio Extra

Today's news in brief

BioWorld

BioWorld briefs for Jan 20, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 20, 2026.

Illustration of human body surrounded by DNA, cell and drug icons

Cell/gene therapy sector now sustainable; China competition mounting

BioWorld

There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...

Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal

BioWorld

With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...

Illustration of magnifying glass inspecting brain

Neurotrimin unveiled as marker in intellectual disability

BioWorld Science

Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...